1,2-Dipropoxybenzene

1,2-Dipropoxybenzene

SCHEMBL578657

CCCOc1ccccc1OCCC

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.56
CYP2C19 P33261 2/20 0.56
CYP2C9 P11712 1/20 0.56
KDM4E B2RXH2 2/20 0.54
L3MBTL1 Q9Y468 4/20 0.54
MAPT P10636 3/20 0.54
NPSR1 Q6W5P4 1/20 0.54
GAA P10253 2/20 0.52
LMNA P02545 2/20 0.52
JAK2 O60674 1/20 0.52
TDP1 Q9NUW8 2/20 0.50
CYP2D6 P10635 1/20 0.50
HTR2C P28335 1/20 0.49
HTR2B P41595 1/20 0.49
TLR8 Q9NR97 1/20 0.48
MCHR1 Q99705 1/20 0.48
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
1,2-Dipropoxybenzene SCHEMBL29428926 1.00 CYP1A2 (0.56) CYP1A2CYP2C19CYP2C9KDM4EL3MBTL1
1,2-Dipropoxybenzene SCHEMBL8910053 0.97 CYP1A2 (0.54) CYP1A2CYP2C19CYP2C9KDM4EL3MBTL1
SCHEMBL10995601 0.93 CYP1A2 (0.50) CYP1A2CYP2C19CYP2C9KDM4EL3MBTL1
1-Propoxy-2-Butoxybenzene SCHEMBL2846696 0.93 CYP1A2 (0.67) CYP1A2CYP2C19CYP2C9KDM4EL3MBTL1
1-Ethoxy-2-Propoxybenzene SCHEMBL2919156 0.93 L3MBTL1 (0.64) CYP1A2CYP2C19CYP2C9KDM4EL3MBTL1
1-Methoxy-2-Propoxybenzene SCHEMBL30827433 0.91 L3MBTL1 (0.60) L3MBTL1MAPTLMNATDP1NPC1
1-Methoxy-2-Propoxybenzene SCHEMBL791386 0.91 L3MBTL1 (0.60) L3MBTL1MAPTLMNATDP1NPC1
SCHEMBL23267299 0.89 L3MBTL1 (0.55) CYP1A2CYP2C19CYP2C9KDM4EL3MBTL1
SCHEMBL7611817 0.89 CYP1A2 (0.47) CYP1A2CYP2C19CYP2C9KDM4EL3MBTL1
SCHEMBL7470539 0.89 CYP1A2 (0.47) CYP1A2CYP2C19CYP2C9KDM4EL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 214 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117964814-A Ziegler-Natta solid catalyst component, catalyst and application thereof 中国石油化工股份有限公司 2024-05-03 CN claimed
CN-116217348-B Preparation method of 1, 2-di-n-propoxybenzene 万华化学集团股份有限公司 2024-05-03 CN claimed
CN-117964812-A Alkoxy magnesium particles, and corresponding catalyst solid component and catalyst system thereof 中国石油化工股份有限公司 2024-05-03 CN claimed
CN-117964813-A Solid catalyst component and catalyst system for olefin polymerization and preparation method thereof 中国石油化工股份有限公司 2024-05-03 CN claimed
CN-115672394-B Preparation method of Cs/Eu-AFN molecular sieve catalyst and preparation method of 1, 2-di-n-propoxybenzene 万华化学集团股份有限公司 2024-02-02 CN claimed
CN-116217348-A Preparation method of 1, 2-di-n-propoxybenzene 万华化学集团股份有限公司 2023-06-06 CN claimed
CN-115672394-A Preparation method of Cs/Eu-AFN molecular sieve catalyst and preparation method of 1,2-di-n-propoxybenzene 万华化学集团股份有限公司 2023-02-03 CN claimed
US-7790629-B2 Atomic layer deposition of strontium oxide via N-propyltetramethyl cyclopentadiendyl precursor THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2010-09-07 US claimed
US-20080242111-A1 Atomic layer deposition of strontium oxide via n-propyltetramethyl cyclopentadiendyl precursor BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY, THE 2008-10-02 US claimed
US-7141635-B2 Catalyst composition and polymerization process using mixtures of selectivity control agents UNION CARBIDE CHEMICALS AND PLASTICS TECH (US) 2006-11-28 US claimed
US-20060167194-A1 Catalyst composition and polymerization process using mixtures of selectivity control agents W. R. GRACE & CO.-CONN. 2006-07-27 US claimed
EP-1313747-B1 METHOD FOR PRODUCING ALKYL-BRIDGED LIGAND SYSTEMS AND TRANSITION METAL COMPOUNDS BASELL POLYOLEFINE GMBH (DE) 2005-04-20 EP claimed
EP-1515996-A2 CATALYST COMPOSITION AND POLYMERIZATION PROCESS USING MIXTURES OF ELECTRON DONORS UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) 2005-03-23 EP claimed
US-6784305-B2 DERIVATIVES OF ZIRCONOCENE DICHLORIDE IN WHICH THE TWO SUBSTITUTED INDENYL GROUPS ARE JOINED TO ONE ANOTHER VIA A BRIDGE CAN, OWING TO THEIR CONFORMATIONAL RIGIDITY, BE USED AS CATALYSTS FOR THE STEREOSPECIFIC POLYMERIZATION OF OLEFINS BASELL POLYOLEFINE GMBH (DE) 2004-08-31 US claimed
WO-2003106512-A2 CATALYST COMPOSITION AND POLYMERIZATION PROCESS USING MIXTURES OF SELECTIVITY CONTROL AGENTS UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION ; (US) 2003-12-24 WO claimed
US-20030199703-A1 Method for producing alkyl-bridged ligand systems and transition metal compounds EQUISTAR CHEMICALS, LP 2003-10-23 US claimed
US-4473713-A Hydrolysis of aryl-aliphatic ethers RHONE-POULENC SPECIALITES CHIMIQUES (FR) 1984-09-25 US claimed
US-20250066515-A1 METHOD FOR PRODUCING SOLID CATALYST COMPONENT FOR OLEFIN POLYMERIZATION, METHOD FOR PRODUCING CATALYST FOR OLEFIN POLYMERIZATION, AND METHOD FOR PRODUCING OLEFIN POLYMER SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2025-02-27 US disclosed
EP-0076220-A1 Process for the hydrolysis of aryl aliphatic ethers RHONE-POULENC SPECIALITES CHIMIQUES (FR) 1983-04-06 EP disclosed
EP-0056156-A1 Method of improving adhesion between rubber and metals BAYER AG (DE) 1982-07-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030199703-A1 Method for producing alkyl-bridged ligand systems and transition metal compounds ABL1, ICMT, ORAI2 CYP1A2 138/4885CYP2C19 1336/4885CYP2C9 933/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.